Goldman Sachs Group Inc Tenaya Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 315,802 shares of TNYA stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
315,802
Previous 219,983
43.56%
Holding current value
$1.13 Million
Previous $681,000
10.57%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$33.7 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$25 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$24.1 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$14.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$11.5 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $148M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...